Surveillance of resected non-small cell lung cancer

• Autores: A. López González, Patricia Ibeas Millán, B. Cantos Sánchez de Ibargüen, Mariano Provencio Pulla
• Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 14, Nº. 10, 2012, págs. 721-725
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Lung cancer is the most common cancer in the world. 15 % of all patients with lung cancer are diagnosed at an early stage, and surgery is the treatment of choice for them. 40 % of all patients survive more than 5 years after surgery, and most of them die as a result of systemic disease. Half of all recurrences are diagnosed within the first 24 months after curative treatment, and 90 % in the first 5 years. Despite this, it is not standardized who should do the monitoring, what additional tests are needed and how often should they be performed. We present here a review on the various recommendations in clinical guidelines.